Literature DB >> 25076138

Factors influencing crystal growth rates from undercooled liquids of pharmaceutical compounds.

Niraj S Trasi1, Jared A Baird, Umesh S Kestur, Lynne S Taylor.   

Abstract

Amorphous forms of drugs are increasingly being used to deliver poorly water-soluble compounds. Therefore, understanding the magnitude and origin of differences in crystallization kinetics is highly important. The goal of this study was to better understand the factors that influence crystal growth rates from pharmaceutically relevant undercooled liquids and to evaluate the range of growth rates observed. The crystal growth rates of 31 drugs were determined using an optical microscope in the temperature region between the glass transition temperature (Tg) and the melting temperature (Tm). Thermodynamic parameters such as Tm, melting enthalpy, and Tg were determined using a differential scanning calorimeter (DSC). Selected viscosity values for the undercooled liquid were taken from the literature. The growth rates of the different compounds were found to be very different from each other with a variation of about 5 orders of magnitude between the fastest growing compounds and the slowest growing compounds. A comparison of the physicochemical properties showed that compounds that had fast crystal growth rates had smaller molecular weights, higher melting temperatures, lower melt entropies, lower melt viscosities, and higher crystal densities. Variations in the growth rates of the compounds could be rationalized to a large extent by considering the thermodynamic driving force for crystallization, the viscosity, and the entropy difference between the melt and undercooled liquid. This study therefore provides important insight into factors that may compromise the stability of amorphous pharmaceuticals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25076138     DOI: 10.1021/jp504450h

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  5 in total

1.  Classification of the crystallization tendency of active pharmaceutical ingredients (APIs) and nutraceuticals based on their nucleation and crystal growth behaviour in solution state.

Authors:  Sneha Rathi; Rahul B Chavan; Nalini R Shastri
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

2.  Evaluation of the Crystallization Tendency of Commercially Available Amorphous Tacrolimus Formulations Exposed to Different Stress Conditions.

Authors:  Niraj S Trasi; Hitesh S Purohit; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-07-07       Impact factor: 4.200

3.  Characterization of amorphous celecoxib mixed with plasticizing (TPGS) and anti-plasticizing (PVP) ingredients using Hot Melt Extrusion.

Authors:  Darlene Santiago; Adlin Mendoza; Zuleyka Morales; Javier Santos
Journal:  J Pharm Innov       Date:  2019-03-13       Impact factor: 2.750

4.  In-situ freeze-drying - forming amorphous solids directly within capsules: An investigation of dissolution enhancement for a poorly soluble drug.

Authors:  Abdulmalik Alqurshi; K L Andrew Chan; Paul G Royall
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

5.  Physical stability of drugs after storage above and below the glass transition temperature: Relationship to glass-forming ability.

Authors:  Amjad Alhalaweh; Ahmad Alzghoul; Denny Mahlin; Christel A S Bergström
Journal:  Int J Pharm       Date:  2015-09-01       Impact factor: 5.875

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.